DIAGENS-B (02526) Surges Over 13% in Early Trading, Company Positioned in World Model Track with Imaging End Prototype Already Launched

DIAGENS-B (02526) rose more than 13% in early trading. As of press time, it was up 6.12% at HK$232.2, with a turnover of HK$26.7043 million.

On the news front, recently, Stanford University postdoctoral fellow Ying Kejun, together with scholars from the University of Washington, Harvard Medical School, MIT and other institutions, released HealthFlux, the first panoramic modality human health world model, on the medical preprint platform medRxiv. It is widely regarded by the industry as a landmark signal of the next "AlphaFold moment" in the medical AI field.

DIAGENS-B (02526)'s self-developed iMedLoop platform has already gathered more than 300 professional annotators and 28.95 million imaging data records, integrating data, tools, models and applications to form a cycle of "data production—model training—clinical application—feedback iteration": feedback generated during clinical use returns to the model, driving the next round of iteration. The imaging understanding, risk prediction and multi-specialty R&D capabilities that DIAGENS has already demonstrated are forming a key piece of the prototype of a medical world model.